An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.

Name: An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases.
License: Public Domain

Novartis Pharmaceuticals

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

choroidal neovascularization, macular edema, glaucoma, neovascular, diabetic retinopathy

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 429658
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.